Outcomes of drug-coated balloon urethral dilation in patients with stricture recurrence after urethroplasty.

ABSTRACT:

Background

Stricture recurrence after urethroplasty can be challenging to manage. Endoscopic intervention has been used with low success within this population. Optilume is a paclitaxel coated balloon dilator that has demonstrated high urethral patency rates and low risk of adverse events in patients with recurrent anterior urethral strictures when compared to endoscopic intervention. The objective of this study was to evaluate the utility of Optilume for treatment of stricture recurrence after urethroplasty.

Methods

We performed a retrospective cohort study of patients who underwent paclitaxel drug-coated balloon (DCB) dilation for urethral stricture recurrences after urethroplasty at two institutions between June 2022 and September 2024. Baseline patient characteristics we

SUBMITTER: Kwenda EP 

PROVIDER: S-EPMC12433171 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature